Molecular events in relapsed oral squamous cell carcinoma: Recurrence vs secondary primary tumor q

Oral Oncology

Volumn 51, Issue 8, 2015, Pages 738-744

  Gleber Netto, Frederico O ^a   Braakhuis, Boudewijn J M ^b   Triantafyllou, Asterios ^c   Takes, Robert P ^d   Kelner, Natalie ^a   Rodrigo, Juan P ^e,f   Strojan, Primož ^g   Poorten, Vincent Vander ^h   Rapidis, Alexander D ⁱ   Rinaldo, Alessandra ^j   Brakenhoff, Ruud H ^b   Ferlito, Alfio ^k   Kowalski, Luiz P ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^g INSTITUTE OF ONCOLOGY   (Slovenia)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ SAINT SAVVAS HOSPITAL   (Greece)

^j UNIVERSITY OF UDINE   (Italy)

^k International Head and Neck Scientific Group   (Brazil)

more..

Author keywords

Molecular diagnosis; Oral cancer; Recurrence; Relapse; Second primary neoplasm; Squamous cell carcinoma

Indexed keywords

CANCER RECURRENCE; CARCINOGENESIS; DISEASE CLASSIFICATION; HUMAN; MOUTH SQUAMOUS CELL CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; GENETICS; HEAD AND NECK TUMOR; MOUTH TUMOR; PATHOLOGY; SECOND CANCER; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY;

EID: 84942826678     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.04.016     Document Type: Review

References (63)

1. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-16.
2. Surveillance Research Program National Cancer Institute. http//seer.cancer.gov/faststats. Fast Stats: An interactive tool for access to SEER cancer statistics. Accessed 10 November 2014.
3. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JWW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345-89.
4. Braakhuis BJM, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 2014;50:670-5.
5. Agra IMG, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006;28:107-13.
6. Hsu SH, Wong YK, Wang CP, Wang CC, Jiang RS, Chen FJ, et al. Survival analysis of patients with oral squamous cell carcinoma with simultaneous second primary tumors. Head Neck 2013;35:1801-7.
7. Yanamoto S, Yamada S, Takahashi H, Yoshitomi G, Kawasaki G, Ikeda H, et al. Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2012;41:1195-200.
8. Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer. Oral Oncol 2009;45:201-11.
9. Gonzalez-Garcia R, Naval-Gias L, Roman-Romero L, Sastre-Perez J, Rodrigues-Campo FJ. Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head Neck 2009;31:1168-80.
10. Koo BS, Lim YC, Lee JS, Choi EC. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol 2006;42:789-94.
11. Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis 2003;9:112-8.
12. Vazquez-Mahia I, Seoane J, Varela-Centelles P, Tomas I, Alvarez Garcia A, Lopez Cedrun JL. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg 2012;70:1724-32.
13. Agra IMG, Carvalho AL, Pinto CAL, Martins EP, Filho JG, Soares FA, et al. Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg 2008;134:743-9.
14. Leemans CR, Tiwari R, Nauta JJP, van de Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 1994;73:187-90.
15. Wunsch-Filho V. The epidemiology of oral and pharynx cancer in Brazil. Oral Oncol 2002;38:737-46.
16. Pateromichelakis S, Farahani M, Phillips E, Partridge M. Molecular analysis of paired tumours: time to start treating the field. Oral Oncol 2005;41:916-26.
17. Kademani D. Oral cancer. Mayo Clin Proc 2007;82:878-87.
18. Ow TJ, Myers JN. Current management of advanced resectable oral cavity squamous cell carcinoma. Clin Exp Otorhinolaryngol 2011;4:1-10.
19. Priante AVM, Carvalho AL, Kowalski LP. Second primary tumor in patients with upper aerodigestive tract cancer. Braz J Otorhinolaryngol 2010;76:251-6.
20. Day GL, Blot WJ. Second primary tumors in patients with oral cancer. Cancer 1992;70:14-9.
21. Morris LGT, Sikora AG, Hayes RB, Patel SG, Ganly I. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control 2011;22:671-9.
22. Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck 2000;22:34-41.
23. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 1932;16:1358-414.
24. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
25. Braakhuis BJM, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 2002;24:198-206.
26. Braakhuis BJM, Brakenhoff RH, Leemans CR. Second field tumors: a new opportunity for cancer prevention? Oncologist 2005;10:493-500.
27. Gutierrez VF, Marcos CA, Llorente JL, Guervos MA, Iglesias FD, Tamargo LA, et al. Genetic profile of second primary tumors and recurrences in head and neck squamous cell carcinomas. Head Neck 2012;34:830-9.
28. Montebugnoli L, Leonardi E, Morandi L, Famedi A, Gissi DB, Marchetti C, et al. Genetic relationship between multiple squamous cell carcinomas arising in the oral cavity. Head Neck 2014;36:94-100.
29. Ronchetti D, Arisi E, Neri A, Pruneri G, Digiuni B, Sambataro G, et al. Microsatellite analyses of recurrence or second primary tumor in head and neck cancer. Anticancer Res 2005;25:2771-6.
30. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, van der Wal JE, Snow GB, Leemans CR, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002;161:1051-60.
31. Partridge M, Pateromichelakis S, Phillips E, Emilion G, Langdon J. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin Cancer Res 2001;7:1860-6.
32. Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res 2000;6:2718-25.
33. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953;6:963-8.
34. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
35. Tabor MP, Brakenhoff RH, van Houten VMM, Kummer JA, Snel MHJ, Snijders PJF, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001;7: 1523-32.
36. Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005;29:167-78.
37. de Carvalho AC, Kowalski LP, Campos AHJFM, Soares FA, Carvalho AL, Vettore AL. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol 2012;48:240-8.
38. Shaw RJ, Hobkirk AJ, Nikolaidis G, Woolgar JA, Triantafyllou A, Brown JS, et al. Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2. Ann Surg Oncol 2013;20:2796-802.
39. Braakhuis BJM, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 2005;15:113-20.
40. Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9-22.
41. Braakhuis BJM, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
42. Ostrovnaya I, Olshen AB, Seshan VE, Orlow I, Albertson DG, Begg CB. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data. Stat Med 2010;29:1608-21.
43. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56: 2484-7.
44. Jang SJ, Chiba I, Hirai A, Hong WK, Mao L. Multiple oral squamous epithelial lesions: are they genetically related? Oncogene 2001;20:2235-42.
45. Escher A, Piotet E, Waridel F, Iggo R, Monnier P. P53 Mutation in histologically normal mucosa of the aero-digestive tract is not a marker of increased risk for second primary carcinoma in head and neck cancer patients. Eur Arch Otorhinolaryngol 2009;266:547-51.
46. Tsui IFL, Garnis C, Poh CF. A dynamic oral cancer field: unraveling the underlying biology and its clinical implication. Am J Surg Pathol 2009;33: 1732-8.
47. Leedham SJ, Wright NA. Human tumour clonality assessment-flawed but necessary. J Pathol 2008;215:351-4.
48. Salk JJ, Horwitz MS. Passenger mutations as a marker of clonal cell lineages in emerging neoplasia. Semin Cancer Biol 2010;20:294-303.
49. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ. Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin Cancer Res 2004;10:3607-13.
50. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333:1157-60.
51. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014;505:495-501.
52. Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015;517:576-82.
53. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011;333:1154-7.
54. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013;499:214-8.
55. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015;43:D805-11.
56. Rennemo E, Zatterstrom U, Boysen M. Outcome of local failures after oral cancer-recurrence vs. second primary. J Oral Pathol Med 2010;39:657-61.
57. Reis PP, Waldron L, Perez-Ordonez B, Pintilie M, Galloni NN, Xuan Y, et al. A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence. BMC Cancer 2011;11:437.
58. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006;12:6716-22.
59. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:39-44.
60. Shibuya H, Amagasa T, Seto K, Ishibashi K, Horiuchi JI, Suzuki S. Leukoplakiaassociated multiple carcinomas in patients with tongue carcinoma. Cancer 1986;57:843-6.
61. Wan Y, Liang F, Nakasone T, Sunakawa H. Development of new leukoplakias and leukoplakia-associated second/multiple primary oral cancers: a case report and literature review. J Oral Maxillofac Surg Med Pathol 2014;26: 166-9.
62. Silverman S, Gorsky M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:154-7.
63. Bagan JV, Murillo J, Poveda R, Gavalda C, Jimenez Y, Scully C. Proliferative verrucous leukoplakia: unusual locations of oral squamous cell carcinomas, and field cancerization as shown by the appearance of multiple OSCCs. Oral Oncol 2004;40:440-3.